101251-27-8Relevant articles and documents
(3,4-Dihydro-quinazolin-2-yl)-indan-1-yl-amines
-
Page/Page column 6, (2010/11/24)
The present invention relates to compounds of formula wherein R1, R2, and n are as defined herein and to pharmaceutically acceptable acid addition salts thereof. The compounds of formula I have a good activity on the 5-HT5A receptor. Therefore, the invention provides the use of a compound of formula I for 5-HT5A receptor related diseases, such as anxiety, depression, sleep disorders and schizophrenia.